HLA class I and class II antigens in Turkish patients with chronic ordinary urticaria
dc.contributor.buuauthor | Aydoğan, Kenan | |
dc.contributor.buuauthor | Karadoğan, Serap Köran | |
dc.contributor.buuauthor | Akdağ, İhsan Ömür | |
dc.contributor.buuauthor | Tunalı, Şükran | |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Dermatoloji Anabilim Dalı. | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Nefroloji Anabilim Dalı. | tr_TR |
dc.contributor.orcid | 0000-0002-0193-1128 | tr_TR |
dc.contributor.researcherid | AAH-6216-2021 | tr_TR |
dc.contributor.scopusid | 9739755800 | tr_TR |
dc.contributor.scopusid | 9738885800 | tr_TR |
dc.contributor.scopusid | 8342488100 | tr_TR |
dc.contributor.scopusid | 7004191748 | tr_TR |
dc.date.accessioned | 2021-10-08T07:30:26Z | |
dc.date.available | 2021-10-08T07:30:26Z | |
dc.date.issued | 2006 | |
dc.description.abstract | Background. Chronic urticaria is a common disease with an unclear pathogenesis, which may be resistant to therapy. Recent studies have focused primarily on a possible autoimmune basis. Aim. To investigate HLA class I and II antigens in a Turkish population with chronic ordinary urticaria (COU; not physical, vasculitic or contact), and identify susceptible HLA antigens. Methods. HLA antigens were investigated in 55 patients diagnosed with COU, using a two-stage microdroplet lymphocytotoxicity test, with 104 healthy and genetically unrelated individuals evaluated as the control group. Results. HLA Bw4 and HLA DQ1 antigens were significantly higher in the study group (odds ratio (OR) = 2.93, 95% CI 1.47-5.85, P = 0.003 and OR = 7.81, 95% CI 1.96-28.50, P = 0.001, respectively) whereas HLA-A24 antigen was higher in controls (OR = 0.36, 95% CI 0.15-0.86, P = 0.03). Conclusion. We propose that HLA-Bw4 and DQ1 antigens may be responsible for susceptibility to COU while HLA-A24 may have a protective role in the Turkish population. | en_US |
dc.identifier.citation | Aydoğan, K. vd. (2006). ''HLA class I and class II antigens in Turkish patients with chronic ordinary urticaria''. Clinical and Experimental Dermatology, 31(3), 424-429. | en_US |
dc.identifier.endpage | 429 | tr_TR |
dc.identifier.issn | 0307-6938 | |
dc.identifier.issn | 1365-2230 | |
dc.identifier.issue | 3 | tr_TR |
dc.identifier.pubmed | 16681593 | tr_TR |
dc.identifier.scopus | 2-s2.0-33645420708 | tr_TR |
dc.identifier.startpage | 424 | tr_TR |
dc.identifier.uri | https://doi.org/10.1111/j.1365-2230.2005.02039.x | |
dc.identifier.uri | https://onlinelibrary.wiley.com/doi/10.1111/j.1365-2230.2005.02039.x | |
dc.identifier.uri | http://hdl.handle.net/11452/22296 | |
dc.identifier.volume | 31 | tr_TR |
dc.identifier.wos | 000236242400025 | |
dc.indexed.pubmed | Pubmed | en_US |
dc.indexed.scopus | Scopus | en_US |
dc.indexed.wos | SCIE | en_US |
dc.language.iso | en | en_US |
dc.publisher | Dermatology | en_US |
dc.relation.journal | Clinical and Experimental Dermatology | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | tr_TR |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Dermatology | en_US |
dc.subject | Edema | en_US |
dc.subject | Linkage | en_US |
dc.subject | Association | en_US |
dc.subject.emtree | HLA DQ1 antigen | en_US |
dc.subject.emtree | HLA B antigen | en_US |
dc.subject.emtree | HLA antigen class 2 | en_US |
dc.subject.emtree | HLA antigen class 1 | en_US |
dc.subject.emtree | HLA antigen | en_US |
dc.subject.emtree | HLA A24 antigen | en_US |
dc.subject.mesh | Urticaria | en_US |
dc.subject.mesh | Turkey | en_US |
dc.subject.mesh | Middle aged | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Logistic models | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | HLA-DQ antigens | en_US |
dc.subject.mesh | HLA-B antigens | en_US |
dc.subject.mesh | HLA-A antigens | en_US |
dc.subject.mesh | HLA antigens | en_US |
dc.subject.mesh | Fluorescent antibody technique | en_US |
dc.subject.mesh | Female | en_US |
dc.subject.mesh | Disease susceptibility | en_US |
dc.subject.mesh | Cytotoxicity tests, immunologic | en_US |
dc.subject.mesh | Chronic disease | en_US |
dc.subject.mesh | Chi-square distribution | en_US |
dc.subject.mesh | Case-control studies | en_US |
dc.subject.mesh | Aged | en_US |
dc.subject.mesh | Adult | en_US |
dc.subject.scopus | Omalizumab; Urticaria; Non-Sedating Histamine H1 Antagonists | tr_TR |
dc.subject.wos | Dermatology | en_US |
dc.title | HLA class I and class II antigens in Turkish patients with chronic ordinary urticaria | en_US |
dc.type | Article | |
dc.wos.quartile | Q3 | en_US |
Files
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: